US Biochip Products and Services Market is Anticipated to Witness High Growth Owing to Advancement in Technologies

 

US Biochip Products and Services Market

The US biochip products and services market includes microarrays, microfluidics devices and biochips which facilitate isolation and visualization of biomolecules such as DNA, RNA and proteins with high sensitivity and accuracy. Biochips find applications in research areas such as functional genomics, proteomics and drug discovery. Advancements in nanotechnology have enabled design of miniaturized lab-on-a-chip biochips for point-of-care diagnostics and testing. Rising demand for personalized medicines and targeted therapeutics is propelling growth of biochip products and services in the country.

The US biochip products and services Market is estimated to be valued at US$ 8.76 Mn in 2024 and is expected to exhibit a CAGR of 6.3% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the US Biochip Products And Services Market Size are Galderma SA, Allergan plc (AbbVie Inc.), Bayer AG, Pfizer Inc., Leo Pharma A/S, Sol-Gel Technologies Ltd., Foamix Pharmaceuticals Ltd., Mayne Pharma, Group Limited, AnaptysBio, Inc., Mylan N.V. These players are focused on developing advanced biochips with compact designs for applications such as cell-based assays, clinical diagnostics and toxicology screening.

The key opportunities in the market include growing demand for disease specific biochips for screening, detection and management of chronic diseases. Biochip platforms are being employed for research in precision medicine, which analyzes an individual’s genes, lifestyle and environment to tailor medical treatment. This is expected to gain greater traction going forward.

Globally, the major players are focused on expansion in territories with high disease burden through establishment of manufacturing and R&D facilities, partnerships, mergers and acquisitions. For instance, in 2022 Abbott completed acquisition of Alinity to strengthen its diagnostics automation portfolio. Such strategic initiatives are aiding global expansion of key players in the US biochip products and services market.

Market drivers:
Growing demand for personalized medicines and targeted therapeutics: Advance biochip are being used for genomic profiling of diseases to develop personalized treatment protocols.
Increasing R&D investments in precision medicine: Major players are investing in development of novel disease specific biochips to accelerate research in precision medicine.

Market restraints:
High costs associated with biochip production: Designing and manufacturing of lab-on-a-chip biochips requires significant investments and expertise which adds to overall costs.
Technical challenges in chip miniaturization: Miniaturization of complex biochemical processes on biochips without compromise on sensitivity and accuracy poses technical challenges.


Segment Analysis
The US biochip products and services market has two main segments - DNA chips and protein chips. DNA chips hold the largest market share currently accounting for around 60% of total sales. These biochips allow for measuring the expression levels of thousands of genes simultaneously and are extensively used for applications such as gene expression profiling, disease diagnosing and genetic testing. Within DNA chips, gene expression arrays remain the largest segment due to their broad use for experimental research in disease pathophysiology and drug discovery. Protein chips are the fastest growing segment with projected annual growth rate of 8% during the forecast period driven by increasing importance of protein analysis in clinical proteomics research. Protein chips are preferred due to ability to study protein functions and interactions on a large scale.

Global Analysis
On regional analysis, North America commands the largest share in the overall US biochip products and services market accounting for over 80% of the revenues currently. This is attributed to presence of leading biochip manufacturers, rapidly growing biotechnology and pharmaceutical industries and continued government funding for life science research in the region. Europe and Asia Pacific follow next helped by increasing R&D investments in personalized medicine and precision diagnostics from both public and private organizations. Among countries, the US holds dominant position with around 75% market share benefiting from availability of advanced healthcare infrastructure and presence of major biochip developers. However, China and India are emerging as lucrative markets registering double digit growth on back of improving research capabilities and expanding patient base requiring gene-based diagnostics or treatment monitoring.

Get more insights on US Biochip Product and Services Market

Also Read Related Article on Idiopathic Hypersomnia Treatment

Comments

Post a Comment

Popular posts from this blog

The global Blast Resistant and Bulletproof Buildings Market Growth Accelerated by Rising Threats

Image
Blast resistant and bulletproof buildings provide protection against explosions, bomb threats and gunfire. They use composite or alloy materials like ballistic glass, reinforced steel and concrete which reinforce structures and withstand blasts or projectiles. The rising threats of terrorist attacks and military aggressions have increased the demand for such secure buildings for government infrastructures, embassies, military installations and other high-security areas. The global Blast Resistant and Bulletproof Buildings Market is estimated to be valued at US$ 1.28 Mn in 2024 and is expected to exhibit a CAGR of 3.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The demand for blast resistant and bulletproof buildings has risen significantly owing to increasing geopolitical conflicts and threats across the world. Majority of countries are allocating higher defense budgets for construction of secure...
Read more

Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market is Anticipated to Witness High Growth Owing to Increasing Business Events

Image
  Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market The Saudi Arabia MICE market refers to meetings, incentives, conferences, and exhibitions which cater to business events in the country. MICE activities help businesses to hold strategy and planning meetings, incentive travel programs, product launches, training seminars, and exhibitions. The events industry helps hotels, airlines, transportation, food & beverage sectors in Saudi Arabia. Growing awareness about MICE and its impact on economy is encouraging businesses to organize more events. The Saudi Vision 2030 aims to diversify economy away from oil and develop tourism and entertainment industries which will further boost the MICE market. The Global Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market is estimated to be valued at US$ 2.69 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031. Key Takeaways Key players operating in ...
Read more

Mometasone Furoate Market Poised for High Growth Due to Rising Prevalence of Respiratory Diseases

Image
  Mometasone Furoate Market Mometasone furoate is a corticosteroid used for the treatment and prevention of asthma, allergic rhinitis, nasal polyps, skin diseases and other inflammatory conditions. It is typically administered as an inhaled medication for asthma and as a topical cream or ointment for skin conditions like dermatitis and eczema. Mometasone furoate works by reducing inflammation and helps ease symptoms like wheezing, breathlessness, and itching caused by various inflammatory reactions in the body. The growing prevalence of asthma and other allergic diseases globally has significantly boosted the demand for mometasone furoate based drugs and products. The global mometasone furoate market is estimated to be valued at US$ 1467.01 Bn in 2024 and is expected to exhibit a CAGR of 22% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the mometasone furoate market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Mil...
Read more